Phagelux is a platform company that utilizes phages, lysins and other biologics and related delivery technologies to create antibacterial products and solutions, particularly targeting antibiotic resistant bacteria strains. Phagelux is headquartered in Shanghai and has a cumulative of four research laboratories worldwide and also manufacturing facilities in both the United States and China. Phagelux has both HumanHealth and AgriHealth divisions (crop sciences, animal health and food safety). The HumanHealth Division has 5 products under development. The AgriHealth division has 9 products already on the market with another 11 under development.